On Invalid Date, Forte Biosciences (NASDAQ: FBRX) reported Q3 2022 earnings per share (EPS) of -$0.18, up 66.67% year over year. Total Forte Biosciences earnings for the quarter were -$3.40 million. In the same quarter last year, Forte Biosciences's earnings per share (EPS) was -$0.54.
As of Q1 2023, Forte Biosciences's earnings has grown year over year. Forte Biosciences's earnings in the past year totalled -$12.34 million.
What is FBRX's earnings date?
Forte Biosciences's earnings date is Invalid Date. Add FBRX to your watchlist to be reminded of FBRX's next earnings announcement.
What was FBRX's revenue last quarter?
On Invalid Date, Forte Biosciences (NASDAQ: FBRX) reported Q3 2022 revenue of $0.00 up N/A year over year. In the same quarter last year, Forte Biosciences's revenue was $0.00.
What was FBRX's revenue growth in the past year?
As of Q1 2023, Forte Biosciences's revenue has grown null year over year. Forte Biosciences's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.